| Tumor macrophages are pivotal constructors of tumor collagenous matrix R Afik, E Zigmond, M Vugman, M Klepfish, E Shimshoni, ... Journal of Experimental Medicine 213 (11), 2315-2331, 2016 | 310 | 2016 |
| Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence M Harel, R Ortenberg, SK Varanasi, KC Mangalhara, M Mardamshina, ... Cell 179 (1), 236-250. e18, 2019 | 224 | 2019 |
| UBQLN4 represses homologous recombination and is overexpressed in aggressive tumors RD Jachimowicz, F Beleggia, J Isensee, BB Velpula, J Goergens, ... Cell 176 (3), 505-519. e22, 2019 | 111 | 2019 |
| Super-SILAC: current trends and future perspectives A Shenoy, T Geiger Expert review of proteomics 12 (1), 13-19, 2015 | 60 | 2015 |
| Uncovering hidden layers of cell cycle regulation through integrative multi-omic analysis R Aviner, A Shenoy, O Elroy-Stein, T Geiger PLoS genetics 11 (10), e1005554, 2015 | 56 | 2015 |
| Mutant eIF 2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease G Raini, R Sharet, M Herrero, A Atzmon, A Shenoy, T Geiger, ... Journal of neurochemistry 141 (5), 694-707, 2017 | 45 | 2017 |
| Proteomic patterns associated with response to breast cancer neoadjuvant treatment A Shenoy, N Belugali Nataraj, G Perry, F Loayza Puch, R Nagel, I Marin, ... Molecular systems biology 16 (9), e9443, 2020 | 43 | 2020 |
| Proteomic analysis of polyribosomes identifies splicing factors as potential regulators of translation during mitosis R Aviner, S Hofmann, T Elman, A Shenoy, T Geiger, R Elkon, M Ehrlich, ... Nucleic acids research 45 (10), 5945-5957, 2017 | 42 | 2017 |
| Distinct extracellular–matrix remodeling events precede symptoms of inflammation E Shimshoni, I Adir, R Afik, I Solomonov, A Shenoy, M Adler, L Puricelli, ... Matrix biology 96, 47-68, 2021 | 26 | 2021 |
| Nascent Ribo-Seq measures ribosomal loading time and reveals kinetic impact on ribosome density J Schott, S Reitter, D Lindner, J Grosser, M Bruer, A Shenoy, T Geiger, ... Nature Methods 18 (9), 1068-1074, 2021 | 18 | 2021 |
| Unraveling the state-specific nature of the native extracellular matrix via multidimensional characterization of its material properties E Shimshoni, R Afik, I Solomonov, I Adir, A Shenoy, M Adler, L Puricelli, ... Preprint at https://doi. org/10.1101/665653, 2019 | 3 | 2019 |
| Proteomic landscape of multi-layered breast cancer internal tumor heterogeneity M Mardamshina, A Shenoy, D Necula, K Krol, D Pirak, N Itzhacky, I Marin, ... bioRxiv, 2021.08. 05.455361, 2021 | 1 | 2021 |
| Multidimensional extracellular-matrix analysis reveals a silent pre-clinical signature in inflammatory disease E Shimshoni, R Afik, A Shenoy, M Adler, L Puricelli, V Ghini, O Mouhadeb, ... bioRxiv, 665653, 2019 | 1 | 2019 |
| Proteolytic Vesicles Derived from Salmonella enterica Serovar Typhimurium-Infected Macrophages: Enhancing MMP-9-Mediated Invasion and EV Accumulation A Nudelman, A Shenoy, H Allouche-Arnon, M Fisler, I Rosenhek-Goldian, ... Biomedicines 12 (2), 434, 2024 | | 2024 |
| Chemoresistome Mapping in Individual Breast Cancer Patients Unravels Diversity in Dynamic Transcriptional Adaptation M Dadiani, G Friedlander, G Perry, N Balint-Lahat, S Gilad, ... bioRxiv, 2023.02. 09.527790, 2023 | | 2023 |
| Publisher Correction: Nascent Ribo-Seq measures ribosomal loading time and reveals kinetic impact on ribosome density (Nature Methods,(2021), 18, 9,(1068-1074), 10.1038/s41592 … J Schott, S Reitter, D Lindner, J Grosser, M Bruer, A Shenoy, T Geiger, ... Nature Methods 20 (2), 316, 2023 | | 2023 |
| Nascent Ribo-Seq measures ribosomal loading time and reveals kinetic impact on ribosome density (vol 18, 1068, 2021) J Schott, S Reitter, D Lindner, J Grosser, M Bruer, A Shenoy, T Geiger, ... NATURE METHODS, 2023 | | 2023 |
| Gastrointestinal adverse events associated with PI3K inhibitors: A disproportionality analysis of FDA adverse event reporting system SK Viswam, R Kamath, J Sharon, A Shivakumar, A Shenoy, L Lukose, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 454-455, 2022 | | 2022 |
| Gastrointestinal adverse events associated with hedgehog pathway inhibitors: A real-world pharmacovigilance study A Shivakumar, A Shenoy, J Sharon, R Kamath, L Lukose, G Kaur, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 593-593, 2022 | | 2022 |
| Abstract P6-03-01: Mapping a personalized chemo-resistome in breast cancer patients by longitudinal transcriptomics M Dadiani, G Friedlander, G Perry, N Balint-Lahat, A Pavlovsky, A Shenoy, ... Cancer Research 80 (4_Supplement), P6-03-01-P6-03-01, 2020 | | 2020 |
